Delirium After Hematopoietic Stem-Cell Transplantation Affects HRQOL

In a stem-cell transplant population, delirium was associated with adverse effects on neurocognition and with high levels of distress at 80 days post-transplant.

Delirium often is perceived as a transient event that resolves without lasting effects; however, a growing body of literature indicates that delirium is associated with poor long-term physical and neuropsychological outcomes. Although delirium is a recognized problem among patients with terminal disease, its incidence and effects are underappreciated in the general oncology population. Using patient-reported outcome measures, investigators conducted a prospective study to assess late effects of delirium on health-related quality of life (HRQOL) in stem-cell transplant patients.

Researchers in Seattle enrolled 90 patients (age range, 22–62 [27% older than 45]; 67% men) who were scheduled for either bone-marrow or stem-cell transplantation (73…

Reviewing Author

Barbara A. Murphy, MD

Delirium After Hematopoietic Stem-Cell Transplantation Affects HRQOL

Topics

Reviewing Author